Clinical Trial Equipment & Ancillary Solutions Market Size

Clinical Trial Equipment & Ancillary Solutions Market Size

Clinical Trial Equipment & Ancillary Solutions Market size was valued at USD 1.5 billion in 2023 and is estimated to grow at 7.5% CAGR from 2024 to 2032. The market experienced significant momentum due to the growing complexity and globalization of clinical trials, leading to increased demand for ancillary solutions. These solutions aim to streamline procedures throughout the studies, responding to the evolving landscape of clinical research.

According to the data by ClinicalTrials.gov reports, as of May 17, 2023, a total (cumulative) of 452,604 registered clinical trials, with 64,838 actively recruiting participants globally. This marked a significant rise from the roughly 365,000 trials recorded in early 2021. Thus, the increasing demand due to the globalization of clinical trials has accelerated market growth significantly, paving the way for extensive market expansion in the foreseeable future.
 

Clinical trial equipment includes a wide range of devices, instruments, and tools used in the conduct of clinical trials to assess the safety and efficacy of clinical studies. This includes diagnostic equipment, laboratory instruments, and supplies tailored to specific research needs. Whereas ancillary solutions refer to supplementary services and support that facilitate various aspects of clinical trials, such as logistics, data management, regulatory compliance, and patient engagement.